Prism Medico and Pharmacy Ltd
š Prism Medico Reports Zero Investor Complaints for Q4 FY26
ā¢ Zero investor complaints reported for quarter ended March 31, 2026
ā¢ No complaints pending at start, received during, or unresolved at end of quarter
ā¢ Compliance report submitted under SEBI Listing Obligations
ā¢ Registrar and Transfer Agent: Purva Sharegistry (India) Pvt. Ltd.
ā¢ Listed on BSE (Scrip Code: 512217) and MSEI (Symbol: PRISMMEDI)
ā¢ ISIN: INE730E01016